Patient Data History and Physical The client is a 34-year-old male with a history of seasonal allergies and asthma. He was jogging this morning and became short of breath. He took one puff of an "emergency inhaler" but is unsure of the name of the medication. Upon exam, the client is anxious, tachypneic, tachycardic, and wheezing. Review history. Which 2 drugs would be the most appropriate to give the client now?

A. Salmeterol via nebulizer: Salmeterol is a long-acting beta-2 agonist (LABA) and is used for maintenance therapy, not for acute bronchospasm. It has a delayed onset of action and is not suitable for emergency relief. B. Albuterol via nebulizer: Albuterol is a short-acting beta-2 agonist (SABA) that acts quickly to relax bronchial smooth muscle, relieving acute bronchospasm. It is one of the first-line treatments during an asthma exacerbation or acute respiratory distress. C. Fexofenadine orally: Fexofenadine is an oral antihistamine used to treat allergic rhinitis, not acute bronchospasm. It would not provide the rapid airway dilation needed in an emergency asthma situation. D. Levalbuterol inhaler: Levalbuterol is another short-acting beta-2 agonist similar to albuterol, used for quick relief of bronchospasm. It is appropriate for emergency use to improve airway obstruction rapidly. E. Racemic epinephrine via nebulizer: Racemic epinephrine is typically used for upper airway obstruction, such as croup or severe airway swelling, not lower airway bronchospasm like in asthma. It is not first-line treatment for an asthma exacerbation. F. Budesonide via metered dose inhaler: Budesonide is an inhaled corticosteroid intended for long-term asthma control, not immediate relief. Its onset is delayed, making it unsuitable for managing acute respiratory distress.